Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Porton Pharma Solutions Ltd.
  6. Company
    300363   CNE100001S57

PORTON PHARMA SOLUTIONS LTD.

(300363)
  Report
End-of-day quote Shenzhen Stock Exchange  -  2022-06-23
76.62 CNY   +10.80%
06/13PORTON PHARMA SOLUTIONS LTD.(SZSE : 300363) added to Shenzhen Stock Exchange Component A Share Index
CI
06/13PORTON PHARMA SOLUTIONS LTD.(SZSE : 300363) added to Shenzhen Stock Exchange Component Index
CI
04/28Porton Pharma Solutions Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Porton Pharma Solutions Ltd., formerly Porton Fine Chemicals Ltd., is a China-based company principally engaged in the provision of customized pharmaceutical research and production services. The Company is also engaged in the multi-client product manufacturing businesses and pharmaceutical and chemical commerce businesses. The products of the Company include anti-viral, anti-diabetic, hypolipidemic, anti-cancer, anesthesia analgesia and anti-bacterial pharmaceuticals, among others. The Company operates its businesses in Europe, North America, Asia and China, among others.

Number of employees : 3 782 people.
Sales per Business
20202021Delta
Late Clinical and Commercial1 448.9569.9%2 038.5765.7% +40.69%
Early Clinical564.4727.2%972.8831.3% +72.35%
Others58.462.8%93.703% +60.27%
CNY in Million
Sales per region
20202021Delta
Foreign1 748.4384.4%2 426.1278.1% +38.76%
China323.4515.6%679.0321.9% +109.94%
CNY in Million
Managers
Name Title Age Since
Nian Feng Ju Chairman & General Manager 49 -
Wei Pi Securities Representative - -
Rong Tao Vice Chairman, Secretary & Deputy General Manager 59 -
Members of the board
Name Title Age Since
Nian Feng Ju Chairman & General Manager 49 -
Yong Qing Guo, Dr. Independent Director 47 -
Pei Min Zheng Independent Director 49 -
Ji Hong Lai, Dr. Independent Director 52 -
Rong Tao Vice Chairman, Secretary & Deputy General Manager 59 -
Xing Ming Li Member-Supervisory Board 47 -
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 550,500,333 285,847,137 51.9% 6,335,013 1.2% 51.9%
Shareholders
NameEquities%
Chongqing Liangjiang New District Industrial Group Co., Ltd. 78,982,719 17.6%
He Bing Zhang 41,903,020 9.36%
Zhong Ou Asset Management Co., Ltd 40,096,061 8.95%
GF Fund Management Co., Ltd. 36,688,414 8.19%
ICBC Credit Suisse Asset Management Co., Ltd. 31,302,584 6.99%
Zhangjiagang Zhuoyuan Investment Ptp LP 27,200,000 6.07%
Jiangsu Ruilian Investment Fund Management Co., Ltd. 23,927,560 5.34%
China Universal Asset Management Co., Ltd. 16,112,225 3.60%
Nian Feng Ju 14,722,630 3.29%
Chongqing Huilin Equity Invt Fund LP 14,442,350 3.22%
Company contact information
Porton Pharma Solutions Ltd.
Fangzheng Avenue
Shuitu Park Zone
Beibei District
Chongqing 400714

Phone : +86.23.65936900
Fax : +86.23.65936901
Web : http://www.porton.cn
Brand Portfolio
In partnership withAllbrands.markets
More brands of Porton Pharma Solutions Ltd.
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
PORTON PHARMA SOLUTIONS LTD.-14.34%6 233
JOHNSON & JOHNSON5.02%462 443
ELI LILLY AND COMPANY17.88%276 070
PFIZER, INC.-15.17%275 327
ABBVIE INC.12.51%260 755
ROCHE HOLDING AG-19.20%259 627
NOVO NORDISK A/S3.80%244 293
MERCK & CO., INC.20.04%225 468
ASTRAZENECA PLC24.31%195 747
NOVARTIS AG-2.55%177 847
BRISTOL-MYERS SQUIBB COMPANY26.64%162 980
AMGEN INC.9.07%128 283
SANOFI13.52%125 452
GSK PLC9.17%105 830
BAYER AG22.96%62 747
DAIICHI SANKYO CO., LTD.10.70%46 113
TAKEDA PHARMACEUTICAL COMPANY LIMITED18.11%42 489
CHUGAI PHARMACEUTICAL CO., LTD-7.01%42 433
JIANGSU HENGRUI MEDICINE CO., LTD.-33.90%31 363
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD-21.70%30 338
ASTELLAS PHARMA INC.14.94%28 769
Connections : Porton Pharma Solutions Ltd.